Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine
NCT00520169
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
intranasal ketamine
Sponsor
Javelin Pharmaceuticals